Risk Factors for Non-completion of Latent Tuberculosis Infection Therapy at an Urban Public Health Clinic

Study design: Retrospective cohort study Study population: Individuals who initiated LTBI therapy at Denver Health in 2013 Exclusion criteria: • ≤18 years of age • Active TB diagnosis • Missing key data (n=76) Data collection: • Treatment completion determined by pharmacy refill data and provider notes in TB clinic electronic medical record. Standard treatment regimens: • INH x 9 months • Rifampin x 4 months • INH and Rifapentine weekly x 3 months Hillary Dunlevy, MD, MPH 12700 E 19th Ave., B168 Aurora, CO 80045 hillary.dunlevy@ucdenver.edu (303)602-8763 phone (303)602-8754 fax